IBO: Impact BioMedical Inc Price Target Chart

Symbol and logo of brand impactbiomedinc.com (IBO)

The share price history of Impact BioMedical Inc (IBO) on the GURU.Markets platform currently stands at 0.00. Business success relies on the demand for new hygiene products and the legal clarity of development rights. Impact BioMedical Inc (IBO) creates a diverse range of medications through partnerships with scientific centers and acquires patents in the field of antivirus software. Since the holding company has not yet entered the sales market, its capitalization is based exclusively on the value of its intellectual assets.

IBO Impact BioMedical, Inc. Price Target Chart (09/17/2024 - 11/11/2026)
Finished products of Impact BioMedical

This indicator synthesizes the aggregate expectations of investment banks regarding the asset's fair value, filtering out short-term market volatility to identify the long-term valuation vector. By analyzing the average target price level, an investor assesses the growth potential, which for the venture business of Impact BioMedical Inc. (IBO) is complicated by a lack of stable revenue and unpredictable cash flows due to high R&D expenditures.

Competitors of Impact BioMedical Inc

Analyst Median Target haleon.com|Analyst Consensus Forecast KVUE (Kenvue)|Verona Pharma PLC - Price Target Chart|MENS - Price Target Chart|Average Forecast Price Ligand Corp|Amneal Pharmaceuticals (AMRX) - Price Target Chart|Forecast Levels Chart PRGO (perrigo.com)|ALVO (Alvotech SA) - Analyst Consensus Forecast|LQDA: Fair Value Consensus|Analyst Consensus Forecast GLPG|Analyst Consensus Forecast ANI Pharmaceuticals Corp (ANIP)|Price Target Chart MannKind Corporation MNKD|Fair Value Consensus AMPH|PCRX - Price Target Chart|ARS Pharmaceuticals Inc (SPRY) - Consensus Target|TBPH: Analyst Consensus Forecast|Aquestive Corp (AQST) - Analyst Consensus Forecast|Consensus Target SCPH|TECX: Fair Value Consensus|Price Target Chart Tonix Pharmaceuticals Holding Corp. (TNXP)|SXTC - Average Forecast Price|Eupraxia Pharmaceuticals Inc. - Consensus Target|Analyst Forecast Prices BHST (BioHarvest Sciences Inc)|eXoZymes Inc - Analyst Consensus Forecast|Fair Value Consensus ORMP (Oramed Pharmaceuticals)|ENTX: Analyst Consensus Forecast|Average Forecast Price MindWalk Holdings, Inc. (HYFT)|Price Target Chart ABVC BioPharma Inc|CPIX: Fair Value Consensus|Analyst Consensus Forecast QNTM|Analyst Median Target fibrogen.com|Price Target Chart Telomir Pharmaceuticals, Inc. TELO|RANI - Consensus Target|SNYR - Price Target Chart|Forecast Levels Chart RLYB|LEXX: Analyst Consensus Forecast|pulmatrix.com (PULM) - Analyst Consensus Forecast|PTHL (Pheton Holdings Limited) - Analyst Consensus Forecast|Consensus Target Aptorum (APM)|Consensus Target LYRA (Lyra Therapeutics, Inc)|Analyst Forecast Prices TNFA|cbdMD - Consensus Target|Fair Value Consensus PRFX|Auris Medical - Analyst Consensus Forecast|LIPO: Price Target Chart|OPTN: Analyst Consensus Forecast|PIRS - Analyst Median Target|Price Target Chart Procaps Group S.A.|Average Forecast Price petrospharma.com PTPI|Price Target Chart Qilian International Holding (QLI)|Consensus Target Acelyrin Inc. SLRN|Analyst Consensus Forecast TFFP (TFF Pharma)